X,
98% of the time you are right-on/dead right, but in this increasing of financial public relations to institutional investors, you are dead-wrong.
Each of the products they are working on will change the world. Just commerciality in ONE is all we need and the institutions will come begging. We are not worth more than the price of the
stock right now. Go back to your biotech analogy. Once we have something we'll be fine.
NO MATTER WHAT THE PRICE OF THE STOCK IS THE DAY BEFORE WE ANNOUNCE.
Patience.
Also hearing what everyone else on the board is hearing: about to buy a local (Delaware) small, private,PROFITABLE, company with minimum dilution.